Telomerase inhibitors from natural products and their anticancer potential

International Journal of Molecular Sciences

Volumn 19, Issue 1, 2018, Pages

  Ganesan, Kumar ^a   Xu, Baojun ^a  

^a BNU HKBU UNITED INTERNATIONAL COLLEGE   (China)

Author keywords

Anticancer; Natural products; Telomerase inhibitors; Telomere

Indexed keywords

ALKALOID; BERBERINE; BOLDINE; CURCUMIN; NATURAL PRODUCT; POLYPHENOL; PRISTIMERIN; PROTEIN P53; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SESQUITERPENE; TANNIN; TELOMERASE; TELOMERASE INHIBITOR; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2; TERPENOID; ANTINEOPLASTIC AGENT; BIOLOGICAL PRODUCT; ENZYME INHIBITOR; TELOMERE BINDING PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BRASSICA OLERACEA; BREAST CANCER; CAMELLIA SINENSIS; CARCINOGENESIS; CELL CYCLE ARREST; CELL PROLIFERATION; COLON ADENOCARCINOMA; DNA DAMAGE; DNA FRAGMENTATION; DOWN REGULATION; FENUGREEK; HUMAN; METASTASIS; MOLECULAR DOCKING; MORTALITY; RECURRENCE RISK; REVIEW; SURVIVAL RATE; ANTAGONISTS AND INHIBITORS; DRUG EFFECT; METABOLISM; NEOPLASM; TELOMERE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BIOLOGICAL PRODUCTS; CELL LINE, TUMOR; ENZYME INHIBITORS; HUMANS; NEOPLASMS; TELOMERASE; TELOMERE; TELOMERE-BINDING PROTEINS;

EID: 85039747534     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms19010013     Document Type: Review

References (246)

1. Popli, D.B.; Sircar, K.; Chowdhry, A. Telomerase: An exploration toward the end of cancer. Indian J. Dent. Res. 2017, 28, 574-584.
2. Zhang, M.Y.; Wang, J.P. A multi-target protein of hTERTR-FAM96A presents significant anticancer potent in the treatment of hepatocellular carcinoma. Tumour Biol. 2017, 39.
3. Ivancich, M.; Schrank, Z.; Wojdyla, L.; Leviskas, B.; Kuckovic, A.; Sanjali, A.; Puri, N. Treating cancer by targeting telomeres and telomerase. Antioxidants 2017, 6.
4. Chung, S.S.; Adekoya, D.; Enenmoh, I.; Clarke, O.; Wang, P.; Sarkyssian, M.; Wu, Y.; Vadgama, J.V. Salinomycin abolished STAT3 and STAT1 interactions and reduced telomerase activity in colorectal cancer cells. Anticancer Res. 2017, 37, 445-453.
5. Odago, F.O.; Gerson, S.L. Telomerase inhibition and telomere erosion: A two-pronged strategy in cancer therapy. Trends Pharmacol. Sci. 2003, 24, 328-331.
6. Parkinson, E.K. Telomerase as a novel and potentially selective target for cancer chemotherapy. Ann. Med. 2003, 35, 466-475.
7. Cian, A.D.; Lacroix, L.; Douarre, C.; Temime-Smaali, N.; Trentesaux, C.; Riou, J.F.; Mergny, J.L. Targeting telomeres and telomerase. Biochimie 2008, 90, 131-155.
8. Autexier, C.; Lue, N.F. The structure and function of telomerase reverse transcriptase. Ann. Rev. Biochem. 2006, 75, 493-517.
9. Hiyama, E.; Hiyama, K. Telomere and telomerase in stem cells. Br. J. Cancer 2007, 96, 1020-1024.
10. Masutomi, K.; Possemato, R.; Wong, J.M.Y.; Currier, J.L.; Tothova, Z.; Manola, J.B.; Ganesan, S.; Lansdorp, P.M.; Collins, K.; Hahn, W.C. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc. Natl. Acad. Sci. USA 2005, 102, 8222-8227.
11. Atkinson, S.P.; Hoare, S.F.; Glasspool, R.M.; Keith, W.N. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Cancer Res. 2005, 65, 7585-7590.
12. Hanahan, D.; Weinberg, R.A. The hallmarks of cancer. Cell 2000, 100, 57-70.
13. Bisoffi, M.; Heaphy, C.M.; Griffith, J.K. Telomeres: Prognostic markers for solid tumors. Int. J. Cancer 2006, 119, 2255-2260.
14. Kazemi-Lomedasht, F.; Rami, A.; Zarghami, N. Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer. Adv. Pharm. Bull. 2013, 3, 127-130.
15. Badrzadeh, F.; Akbarzadeh, A.; Zarghami, N.; Yamchi, M.R.; Zeighamian, V.; Tabatabae, F.S.; Taheri, M.; Kafil, H.S. Comparison between effects of free curcumin and curcumin loaded NIPAAm-MAA nanoparticles on telomerase and PinX1 gene expression in lung cancer cells. Asian Pac. J. Cancer Prev. 2014, 15, 8931-8936.
16. Nasiri, M.; Zarghami, N.; Koshki, K.N.; Mollazadeh, M.; Moghaddam, M.P.; Yamchi, M.R.; Esfahlan, R.J.; Barkhordari, A.; Alibakhshi, A. Curcumin and silibinin inhibit telomerase expression in T47D human breast cancer cells. Asian Pac. J. Cancer Prev. 2013, 14, 3449-3453.
17. Chan, S.W.-L.; Blackburn, E.H. New ways not to make ends meet: Telomerase, DNA damage proteins and heterochromatin. Oncogene 2002, 21, 553-563.
18. Celli, G.B.; de Lange, T. DNA processing is not required for ATM mediated telomere damage response after TRF2 deletion. Nat. Cell Biol. 2005, 7, 712-718.
19. De Lange, T. How telomeres solve the end-protection problem. Science 2009, 326, 948-952.
20. Sfeir, A.; Kabir, S.; van Overbeek, M.; Celli, G.B.; de Lange, T. Loss of Rap1 induces telomere recombination in the absence of NHEJ or a DNA damage signal. Science 2010, 327, 1657-1661.
21. Lai, K.H.; Liu, Y.C.; Su, J.H.; El-Shazly, M.; Wu, C.F.; Du, Y.C.; Hsu, Y.M.; Yang, J.C.; Weng, M.K.; Chou, C.H.; et al. Antileukemic scalarane sesterterpenoids and meroditerpenoid from Carteriospongia (Phyllospongia) sp., induce apoptosis via dual inhibitory effects on topoisomerase II and Hsp90. Sci. Rep. 2016, 6, 36170.
22. Chini, M.G.; Malafronte, N.; Vaccaro, M.C.; Gualtieri, M.J.; Vassallo, A.; Vasaturo, M.; Castellano, S.; Milite, C.; Leone, A.; Bifulco, G.; et al. Identification of limonol derivatives as heat shock protein 90 (Hsp90) inhibitors through a multidisciplinary approach. Chemistry 2016, 22, 13236-13250.
23. Zhang, Z.; Xue, N.; Bian, C.; Yan, R.; Jin, L.; Chen, X.; Yu, X. C15-methoxyphenylated 18-deoxy-herbimycin A analogues, their in vitro anticancer activity and heat shock protein 90 binding affinity. Bioorg. Med. Chem. Lett. 2016, 26, 4287-4291.
24. Noureini, S.K.; Tanavar, F. Boldine, a natural aporphine alkaloid, inhibits telomerase at non-toxic concentrations. Chem. Biol. Interact. 2015, 231, 27-34.
25. Platella, C.; Guida, S.; Bonmassar, L.; Aquino, A.; Bonmassar, E.; Ravagnan, G.; Montesarchio, D.; Roviello, G.N.; Musumeci, D.; Fuggetta, M.P. Antitumour activity of resveratrol on human melanoma cells: A possible mechanism related to its interaction with malignant cell telomerase. Biochim. Biophys. Acta 2017, 1861, 2843-2851.
26. Han, M.H.; Lee, D.S.; Jeong, J.W.; Hong, S.H.; Choi, I.W.; Cha, H.J.; Kim, S.; Kim, H.S.; Park, C.; Kim, G.Y.; et al. Fucoidan induces ROS-dependent apoptosis in 5637 human bladder cancer cells by downregulating telomerase activity via inactivation of the PI3K/Akt signaling pathway. Drug Dev. Res. 2017, 78, 37-48.
27. Kim, Y.J.; Kwon, H.C.; Ko, H.; Park, J.H.; Kim, H.Y.; Yoo, J.H.; Yang, H.O. Anti-tumor activity of the ginsenoside Rk1 in human hepatocellular carcinoma cells through inhibition of telomerase activity and induction of apoptosis. Biol. Pharm. Bull. 2008, 31, 826-830.
28. Moirangthem, D.S.; Laishram, S.; Borah, J.C.; Kalita, M.C.; Talukdar, N.C. Cephalotaxus griffithii Hook.f. needle extract induces cell cycle arrest, apoptosis and suppression of hTERT and hTR expression on human breast cancer cells. BMC Complement. Altern. Med. 2014, 14, 305.
29. Huang, S.T.; Wang, C.Y.; Yang, R.C.; Chu, C.J.; Wu, H.T.; Pang, J.H. Phyllanthus urinaria increases apoptosis and reduces telomerase activity in human nasopharyngeal carcinoma cells. Forsch. Komplementmed. 2009, 16, 34-40.
30. Huang, S.T.; Wang, C.Y.; Yang, R.C.; Chu, C.J.; Wu, H.T.; Pang, J.H. Wogonin, an active compound in Scutellaria baicalensis, induces apoptosis and reduces telomerase activity in the HL-60 leukemia cells. Phytomedicine 2010, 17, 47-54.
31. Woo, H.J.; Choi, Y.H. Growth inhibition of A549 human lung carcinoma cells by beta-lapachone through induction of apoptosis and inhibition of telomerase activity. Int. J. Oncol. 2005, 26, 1017-1023.
32. Oyama, J.I.; Shiraki, A.; Nishikido, T.; Maeda, T.; Komoda, H.; Shimizu, T.; Makino, N.; Node, K. EGCG, a green tea catechin, attenuates the progression of heart failure induced by the heart/muscle-specific deletion of MnSOD in mice. J. Cardiol. 2017, 69, 417-427.
33. Nagle, D.G.; Ferreira, D.; Zhou, Y.D. Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives. Phytochemistry 2006, 67, 1849-1855.
34. Liao, C.Y.; Lee, C.L.; Wang, H.C.; Liang, S.S.; Kung, P.H.; Wu, Y.C.; Chang, F.R.; Wu, C.C. CLL2-1, a chemical derivative of orchid 1,4-phenanthrenequinones, inhibits human platelet aggregation through thiol modification of calcium-diacylglycerol guanine nucleotide exchange factor-I (CalDAG-GEFI). Free Radic. Biol. Med. 2015, 78, 101-110.
35. Sheremet, M.; Kapoor, S.; Schröder, P.; Kumar, K.; Ziegler, S.; Waldmann, H. Small molecules inspired by the natural product withanolides as potent inhibitors of Wnt signaling. Chembiochem 2017, 18, 1797-1806.
36. Han, L.; Bian, H.; Ouyang, J.; Bi, Y.; Yang, L.; Ye, S. Wenyang Huazhuo Tongluo formula, a Chinese herbal decoction, improves skin fibrosis by promoting apoptosis and inhibiting proliferation through down-regulation of survivin and cyclin D1 in systemic sclerosis. BMC Complement. Altern. Med. 2016, 16.
37. Franceschin, M.; Rossetti, L.; D’Ambrosio, A.; Schirripa, S.; Bianco, A.; Ortaggi, G.; Savino, M.; Schultes, C.; Neidle, S. Natural and synthetic G-quadruplex interactive berberine derivatives. Bioorg. Med. Chem. Lett. 2006, 16, 1707-1711.
38. Kim, M.O.; Moon, D.O.; Choi, Y.H.; Shin, D.Y.; Kang, H.S.; Choi, B.T.; Lee, J.D.; Li, W.; Kim, G.Y. Platycodin D induces apoptosis and decreases telomerase activity in human leukemia cells. Cancer Lett. 2008, 261, 98-107.
39. Park, S.E.; Park, C.; Kim, S.H.; Hossain, M.A.; Kim, M.Y.; Chung, H.Y.; Son, W.S.; Kim, G.Y.; Choi, Y.H.; Kim, N.D. Korean red ginseng extract induces apoptosis and decreases telomerase activity in human leukemia cells. J. Ethnopharmacol. 2009, 121, 304-312.
40. Chiruvella, K.K.; Raghavan, S.C. A natural compound, methyl angolensate, induces mitochondrial pathway of apoptosis in Daudi cells. Invest. New Drugs 2011, 29, 583-592.
41. Feng, H.; Guo, B.; Kong, X.; Wu, B. Evodiamine enhances the radiosensitivity of esophageal squamous cell cancer Eca-109 cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2016, 32, 940-944.
42. Shirode, A.B.; Kovvuru, P.; Chittur, S.V.; Henning, S.M.; Heber, D.; Reliene, R. Antiproliferative effects of pomegranate extract in MCF-7 breast cancer cells are associated with reduced DNA repair gene expression and induction of double strand breaks. Mol. Carcinog. 2014, 53, 458-470.
43. Pan, X.H.C.; Zeng, F.; Zhang, S.; Xu, J. Isolation and identification of alkaloids from Menispermum dauricum growing in Xianning. Zhong Yao Cai 1998, 21, 456-458.
44. Ji, X.; Sun, H.; Zhou, H.; Xiang, J.; Tang, Y.; Zhao, C. The interaction of telomeric DNA and C-myc22 G-quadruplex with 11 natural alkaloids. Nucleic Acid Ther. 2012, 22, 127-136.
45. Kumari, S.; Nayak, G.; Lukose, S.T.; Kalthur, S.G.; Bhat, N.; Hegde, A.R.; Mutalik, S.; Kalthur, G.; Adiga, S.K. Indian propolis ameliorates the mitomycin C-induced testicular toxicity by reducing DNA damage and elevating the antioxidant activity. Biomed. Pharmacother. 2017, 95, 252-263.
46. Hajjar, D.; Kremb, S.; Sioud, S.; Emwas, A.H.; Voolstra, C.R.; Ravasi, T. Anti-cancer agents in Saudi Arabian herbals revealed by automated high-content imaging. PLoS ONE 2017, 12, e0177316.
47. Sun, M.F.; Chang, T.T.; Chang, K.W.; Huang, H.J.; Chen, H.Y.; Tsai, F.J.; Lin, J.G.; Chen, C.Y. Blocking the DNA repair system by traditional Chinese medicine? J. Biomol. Struct. Dyn. 2011, 28, 895-906.
48. Alam, F.; Us Saqib, Q.N.; Waheed, A. Cytotoxic activity of extracts and crude saponins from Zanthoxylum armatum DC. against human breast (MCF-7, MDA-MB-468) and colorectal (Caco-2) cancer cell lines. BMC Complement. Altern. Med. 2017, 17, 368.
49. Sarvesvaran, J.; Going, J.J.; Milroy, R.; Kaye, S.B.; Keith, W.N. Is small cell lung cancer the perfect target for anti-telomerase treatment? Carcinogenesis 1999, 20, 1649-1651.
50. Kumaki, F.; Kawai, T.; Hiroi, S.; Shinomiya, N.; Ozeki, Y.; Ferrans, V.J.; Torikata, C. Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas. Hum. Pathol. 2001, 32, 188-195.
51. Oztas, E.; Kara, H.; Kara, Z.P.; Aydogan, M.U.; Uras, C.; Ozhan, G. Association between human telomerase reverse transcriptase gene variations and risk of developing breast cancer. Genet. Test. Mol. Biomarkers 2016, 20, 459-464.
52. Shi, M.; Zheng, J.; Liu, C.; Tan, G.; Qing, Z.; Yang, S.; Yang, J.; Tan, Y.; Yang, R. SERS assay of telomerase activity at single-cell level and colon cancer tissues via quadratic signal amplification. Biosens. Bioelectron. 2016, 77, 673-680.
53. Yu, S.A.; Peng, C.H.; Wu, R.J.; Zheng, Z.D.; Chen, K.; Fu, Z.N. Detection of telomerase activity of exfoliated cells in bile and its clinical impact. Ai Zheng 2002, 21, 177-180.
54. Barbosa, L.C.; da Silva, I.D.; Corrêa, J.C.; Ribalta, J.C. Survivin and telomerase expression in the uterine cervix of women with human papillomavirus-induced lesions. Int. J. Gynecol. Cancer 2011, 21, 15-21.
55. Wang, S.; Chen, X.; Tang, M. Quantitative assessment of the diagnostic role of human telomerase activity from pancreatic juice in pancreatic cancer. Tumour Biol. 2014, 35, 7897-7904.
56. Yano, Y.; Yoshida, K.; Osaki, A.; Toge, T.; Tahara, H.; Ide, T.; Yasui, W. Expression and distribution of human telomerase catalytic component, hTERT, in human breast tissues. Anticancer Res. 2002, 22, 4101-4107.
57. Boldrini, L.; Faviana, P.; Gisfredi, S.; Zucconi, Y.; Di Quirico, D.; Donati, V.; Berti, P.; Spisni, R.; Galleri, D.; Materazzi, G.; et al. Evaluation of telomerase mRNA (hTERT) in colon cancer. Int. J. Oncol. 2002, 21, 493-497.
58. Bonatz, G.; Frahm, S.O.; Klapper, W.; Helfenstein, A.; Heidorn, K.; Jonat, W.; Krupp, G.; Parwaresch, R.; Rudolph, P. High telomerase activity is associated with cell cycle deregulation and rapid progression in endometrioid adenocarcinoma of the uterus. Hum. Pathol. 2001, 32, 605-614.
59. Chen, C.H.; Chen, R.J. Prevalence of telomerase activity in human cancer. J. Formos. Med. Assoc. 2011, 110, 275-289.
60. Sidorova, N.; Zavalishina, L.; Kurchashova, S.; Korsakova, N.; Nazhimov, V.; Frank, G.; Kuimov, A. Immunohistochemical detection of tankyrase 2 in human breast tumors and normal renal tissue. Cell Tissue Res. 2006, 323, 137-145.
61. Itoi, T.; Shinohara, Y.; Takeda, K.; Nakamura, K.; Shimizu, M.; Ohyashiki, K.; Hisatomi, H.; Nakano, H.; Moriyasu, F. Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers. Int. J. Mol. Med. 2001, 7, 281-287.
62. Man, Y.; Cao, J.; Jin, S.; Xu, G.; Pan, B.; Shang, L.; Che, D.; Yu, Q.; Yu, Y. Newly identified biomarkers for detecting circulating tumor cells in lung adenocarcinoma. Tohoku J. Exp. Med. 2014, 234, 29-40.
63. Hilal, G.; Reitzel, R.; Al Hamal, Z.; Chaftari, A.M.; Al Wohoush, I.; Jiang, Y.; Hachem, R.; Raad, I.I. Novel plasma telomerase detection method to improve cancer diagnostic assessment. PLoS ONE 2017, 12, e0174266.
64. Glybochko, P.V.; Zezerov, E.G.; Glukhov, A.I.; Alyaev, Y.G.; Severin, S.E.; Polyakovsky, K.A.; Varshavsky, V.A.; Severin, E.S.; Vinarov, A.Z. Telomerase as a tumor marker in diagnosis of prostatic intraepithelial neoplasia and prostate cancer. Prostate 2014, 74, 1043-1051.
65. Mora, J.; Lerma, E. Thyroid Neoplasia Study Group. Telomerase activity in thyroid fine needle aspirates. Acta Cytol. 2004, 48, 818-824.
66. Capezzone, M.; Marchisotta, S.; Cantara, S.; Pacini, F. Telomeres and thyroid cancer. Curr. Genom. 2009, 10, 526-533.
67. Koonrungsesomboon, N.; Wadagni, A.C.; Mbanefo, E.C. Molecular markers and Schistosoma-associated bladder carcinoma: A systematic review and meta-analysis. Cancer Epidemiol. 2015, 39, 487-496.
68. Lou, X.; Zhuang, Y.; Zuo, X.; Jia, Y.; Hong, Y.; Min, X.; Zhang, Z.; Xu, X.; Liu, N.; Xia, F.; et al. Real-time, quantitative lighting-up detection of telomerase in urines of bladder cancer patients by AIEgens. Anal. Chem. 2015, 87, 6822-6827.
69. Hapangama, D.K.; Kamal, A.; Saretzki, G. Implications of telomeres and telomerase in endometrial pathology. Hum. Reprod. Update 2017, 23, 166-187.
70. Jahanban-Esfahlan, R.; Seidi, K.; Monfaredan, A.; Shafie-Irannejad, V.; Abbasi, M.M.; Karimian, A.; Yousefi, B. The herbal medicine Melissa officinalis extract effects on gene expression of p53, Bcl-2, Her2, VEGF-A and hTERT in human lung, breast and prostate cancer cell lines. Gene 2017, 613, 14-19.
71. Noguchi, M.; Yokoyama, M.; Watanabe, S.; Uchiyama, M.; Nakao, Y.; Hara, K.; Iwasaka, T. Inhibitory effect of the tea polyphenol, (-)-epigallocatechin gallate, on growth of cervical adenocarcinoma cell lines. Cancer Lett. 2006, 234, 135-142.
72. Demir, S.; Turan, I.; Aliyazicioglu, Y.; Kilinc, K.; Yaman, S.O.; Ayazoglu Demir, E.; Arslan, A.; Mentese, A.; Deger, O. Morus rubra extract induces cell cycle arrest and apoptosis in human colon cancer cells through endoplasmic reticulum stress and telomerase. Nutr. Cancer 2017, 69, 74-83.
73. Guo, W.Q.; Li, L.Z.; He, Z.Y.; Zhang, Q.; Liu, J.; Hu, C.Y.; Qin, F.J.; Wang, T.Y. Anti-proliferative effects of Atractylis lancea (Thunb.) DC. via down-regulation of the c-myc/hTERT/telomerase pathway in Hep-G2 cells. Asian Pac. J. Cancer Prev. 2013, 14, 6363-6367.
74. Abliz, G.; Mijit, F.; Hua, L.; Abdixkur, G.; Ablimit, T.; Amat, N.; Upur, H. Anti-carcinogenic effects of the phenolic-rich extract from abnormal Savda Munziq in association with its cytotoxicity, apoptosis-inducing properties and telomerase activity in human cervical cancer cells (SiHa). BMC Complement. Altern. Med. 2015, 15, 23.
75. Xu, B.; Sung, C.K. Screening of Telomerase Inhibitor from Natural Products and Their Anticancer Activities. Ph.D. Thesis, Chungnam National University, Taejon, Korea, 5 February 2005.
76. Chen, J.L.-Y.; Sperry, J.; Ip, N.Y.; Brimble, M.A. Natural products targeting telomere maintenance. MedChemComm 2011, 2, 229.
77. Xu, B.; Wang, Q.; Sung, C.K. Telomerase inhibitory effects of red pigment rubropunctatin and Statin monacolin L isolated from red yeast rice. Genes 2017, 8, 129.
78. Mohammad, R.Y.; Somayyeh, G.; Gholamreza, H.; Majid, M.; Yousef, R. Diosgenin inhibits hTERT gene expression in the A549 lung cancer cell line. Asian Pac. J. Cancer Prev. 2013, 14, 6945-6948.
79. Rahmati-Yamchi, M.; Ghareghomi, S.; Haddadchi, G.; Milani, M.; Aghazadeh, M.; Daroushnejad, H. Fenugreek extract diosgenin and pure diosgenin inhibit the hTERT gene expression in A549 lung cancer cell line. Mol. Biol. Rep. 2014, 41, 6247-6252.
80. Noureini, S.K.; Wink, M. Antiproliferative effect of the isoquinoline alkaloid papaverine in hepatocarcinoma HepG-2 cells-Inhibition of telomerase and induction of senescence. Molecules 2014, 19, 11846-11859.
81. Chen, Y.; Zhang, Y. Functional and mechanistic analysis of telomerase: An antitumor drug target. Pharmacol. Ther. 2016, 163, 24-47.
82. Xu, B.; Li, C.; Sung, C.K. Telomerase inhibitory effects of medicinal mushrooms and lichens, and their anticancer activity. Int. J. Med. Mushrooms 2014, 16, 17-28.
83. Xu, B.; Sung, C.K. Telomerase inhibitory effects and anti-proliferative properties of onion and other natural spices against cancer cells. Food Biosci. 2015, 10, 80-85.
84. Marconett, C.N.; Sundar, S.N.; Tseng, M.; Tin, A.S.; Tran, K.Q.; Mahuron, K.M.; Bjeldanes, L.F.; Firestone, G.L. Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G1 cell cycle arrest of human breast cancer cells. Carcinogenesis 2011, 32, 1315-1323.
85. Lin, S.C.; Li, W.C.; Shih, J.W.; Hong, K.F.; Pan, Y.R.; Lin, J.J. The tea polyphenols EGCG and EGC repress mRNA expression of human telomerase reverse transcriptase (hTERT) in carcinoma cells. Cancer Lett. 2006, 236, 80-88.
86. Tuntiwechapikul, W.; Taka, T.; Songsomboon, C.; Kaewtunjai, N.; Imsumran, A.; Makonkawkeyoon, L.; Pompimon, W.; Lee, T.R. Ginger extract inhibits human telomerase reverse transcriptase and c-Myc expression in A549 lung cancer cells. J. Med. Food 2010, 13, 1347-1354.
87. Lin, P.C.; Lin, S.Z.; Chen, Y.L.; Chang, J.S.; Ho, L.I.; Liu, P.Y.; Chang, L.F.; Harn, Y.C.; Chen, S.P.; Sun, L.Y.; et al. Butylidenephthalide suppresses human telomerase reverse transcriptase (TERT) in human glioblastomas. Ann. Surg. Oncol. 2011, 18, 3514-3527.
88. Lanzilli, G.; Fuggetta, M.P.; Tricarico, M.; Cottarelli, A.; Serafino, A.; Falchetti, R.; Ravagnan, G.; Turriziani, M.; Adamo, R.; Franzese, O.; et al. Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro. Int. J. Oncol. 2006, 28, 641-648.
89. Noureini, S.K.; Wink, M. Antiproliferative effects of crocin in HepG2 cells by telomerase inhibition and hTERT down-regulation. Asian Pac. J. Cancer Prev. 2012, 13, 2305-2309.
90. Verma, A.K.; Pratap, R. The biological potential of flavones. Nat. Prod. Rep. 2010, 27, 1571-1593.
91. Park, C.; Jung, J.H.; Kim, N.D.; Choi, Y.H. Inhibition of cyclooxygenase-2 and telomerase activities in human leukemia cells by dideoxypetrosynol A, a polyacetylene from the marine sponge Petrosia sp. Int. J. Oncol. 2007, 30, 291-298.
92. Park, C.; Kim, G.Y.; Kim, W.I.; Hong, S.H.; Park, D.I.; Kim, N.D.; Bae, S.J.; Jung, J.H.; Choi, Y.H. Induction of apoptosis by (Z)-stellettic acid C, an acetylenic acid from the sponge Stelletta sp., is associated with inhibition of telomerase activity in human leukemic U937 cells. Chemotherapy 2007, 53, 160-168.
93. Park, D.I.; Lee, J.H.; Moon, S.K.; Kim, C.H.; Lee, Y.T.; Cheong, J.; Choi, B.T.; Choi, Y.H. Induction of apoptosis and inhibition of telomerase activity by aqueous extract from Platycodon grandiflorum in human lung carcinoma cells. Pharmacol. Res. 2005, 51, 437-443.
94. Liu, J.J.; Chen, G.Y.; Wang, M.; Yang, Z.Y.; Hong, X. Effects of vinorelbine on apoptosis and expression of telomerase activity in human lung adenocarcinoma cells in vitro. Zhonghua Zhong Liu Za Zhi 2010, 32, 743-747.
95. Jagadeesh, S.; Kyo, S.; Banerjee, P.P. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells. Cancer Res. 2006, 66, 2107-2115.
96. Li, Y.; Liu, L.; Andrews, L.G.; Tollefsbol, T.O. Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms. Int. J. Cancer 2009, 125, 286-296.
97. Woo, H.J.; Lee, S.J.; Choi, B.T.; Park, Y.M.; Choi, Y.H. Induction of apoptosis and inhibition of telomerase activity by trichostatin A, a histone deacetylase inhibitor, in human leukemic U937 cells. Exp. Mol. Pathol. 2007, 82, 77-84.
98. Mittal, A.; Pate, M.S.; Wylie, R.C.; Tollefsbol, T.O.; Katiyar, S.K. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int. J. Oncol. 2004, 24, 703-710.
99. Meeran, S.M.; Patel, S.N.; Chan, T.H.; Tollefsbol, T.O. A novel prodrug of epigallocatechin-3-gallate: Differential epigenetic hTERT repression in human breast cancer cells. Cancer Prev. Res. 2011, 4, 1243-1254.
100. Adler, S.; Rashid, G.; Klein, A. Indole-3-carbinol inhibits telomerase activity and gene expression in prostate cancer cell lines. Anticancer Res. 2011, 31, 3733-3737.
101. Ramachandran, C.; Fonseca, H.B.; Jhabvala, P.; Escalon, E.A.; Melnick, S.J. Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line. Cancer Lett. 2002, 184, 1-6.
102. Mukherjee Nee Chakraborty, S.; Ghosh, U.; Bhattacharyya, N.P.; Bhattacharya, R.K.; Dey, S.; Roy, M. Curcumin-induced apoptosis in human leukemia cell HL-60 is associated with inhibition of telomerase activity. Mol. Cell. Biochem. 2007, 297, 31-39.
103. Singh, M.; Singh, N. Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells. Mol. Cell. Biochem. 2009, 325, 107-119.
104. Choi, S.H.; Lyu, S.Y.; Park, W.B. Mistletoe lectin induces apoptosis and telomerase inhibition in human A253 cancer cells through dephosphorylation of Akt. Arch. Pharm. Res. 2004, 27, 68-76.
105. Liao, C.H.; Hsiao, Y.M.; Hsu, C.P.; Lin, M.Y.; Wang, J.C.; Huang, Y.L.; Ko, J.L. Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from Ganoderma tsugae in A549 human lung adenocarcinoma cell line. Mol. Carcinog. 2006, 45, 220-229.
106. Han, M.H.; Kim, G.Y.; Moon, S.K.; Kim, W.J.; Nam, T.J.; Choi, Y.H. Apoptosis induction by glycoprotein isolated from Laminaria japonica is associated with down-regulation of telomerase activity and prostaglandin E2 synthesis in AGS human gastric cancer cells. Int. J. Oncol. 2011, 38, 577-584.
107. Chakrabarti, M.; Banik, N.L.; Ray, S.K. Sequential hTERT knockdown and apigenin treatment inhibited invasion and proliferation and induced apoptosis in human malignant neuroblastoma SK-N-DZ and SK-N-BE2 cells. J. Mol. Neurosci. 2013, 51, 187-198.
108. Jayasooriya, R.G.; Kang, S.H.; Kang, C.H.; Choi, Y.H.; Moon, D.O.; Hyun, J.W.; Chang, W.Y.; Kim, G.Y. Apigenin decreases cell viability and telomerase activity in human leukemia cell lines. Food Chem. Toxicol. 2012, 50, 2605-2611.
109. Kang, S.-S.; Lim, S.-E. Growth and telomerase inhibition of SK-MEL 28 melanoma cell line by a plant flavonoid, apigenin. BMB Rep. 1998, 31, 339-344.
110. Park, S.E.; Yoo, H.S.; Jin, C.Y.; Hong, S.H.; Lee, Y.W.; Kim, B.W.; Lee, S.H.; Kim, W.J.; Cho, CK.; Choi, Y.H. Induction of apoptosis and inhibition of telomerase activity in human lung carcinoma cells by the water extract of Cordyceps militaris. Food Chem. Toxicol. 2009, 47, 1667-1675.
111. Vale, P.; de M Sampayo, M.A. Pectenotoxin-2 seco acid, 7-epi-pectenotoxin-2 seco acid and pectenotoxin-2 in shellfish and plankton from Portugal. Toxicon 2002, 40, 979-987.
112. Han, Q.B.; Xu, H.X. Caged Garcinia xanthones: Development since 1937. Curr. Med. Chem. 2009, 16, 3775-3796.
113. Yu, J.; Guo, Q.L.; You, Q.D.; Lin, S.S.; Li, Z.; Gu, H.Y.; Zhang, H.W.; Tan, Z.; Wang, X. Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells. Cancer Chemother. Pharmacol. 2006, 58, 434-443.
114. Sun, L.; Wang, X. Effects of allicin on both telomerase activity and apoptosis in gastric cancer SGC-7901 cells. World J. Gastroenterol. 2003, 9, 1930-1934.
115. Ye, Y.; Yang, H.Y.; Wu, J.; Li, M.; Min, J.M.; Cui, J.R. Z-ajoene causes cell cycle arrest at G2/M and decrease of telomerase activity in HL-60 cells. Zhonghua Zhong Liu Za Zhi 2005, 27, 516-520.
116. Aggarwal, B.B.; Bhardwaj, A.; Aggarwal, R.S.; Seeram, N.P.; Shishodia, S.; Takada, Y. Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res. 2004, 24, 2783-2840.
117. Kala, R.; Shah, H.N.; Martin, S.L.; Tollefsbol, T.O. Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer. BMC Cancer 2015, 15, 672.
118. Kanno, S.; Kitajima, Y.; Kakuta, M.; Osanai, Y.; Kurauchi, K.; Ujibe, M.; Ishikawa, M. Costunolide-induced apoptosis is caused by receptor-mediated pathway and inhibition of telomerase activity in NALM-6 cells. Biol. Pharm. Bull. 2008, 31, 1024-1028.
119. Choi, S.H.; Im, E.; Kang, H.K.; Lee, J.H.; Kwak, H.S.; Bae, Y.T.; Park, H.J.; Kim, N.D. Inhibitory effects of costunolide on the telomerase activity in human breast carcinoma cells. Cancer Lett. 2005, 227, 153-162.
120. Thelen, P.; Wuttke, W.; Jarry, H.; Grzmil, M.; Ringert, R.H. Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells. J. Urol. 2004, 171, 1934-1938.
121. Long, C.; Wang, J.; Guo, W.; Wang, H.; Wang, C.; Liu, Y.; Sun, X. Triptolide inhibits transcription of hTERT through down-regulation of transcription factor specificity protein 1 in primary effusion lymphoma cells. Biochem. Biophys. Res. Commun. 2016, 469, 87-93.
122. Moon, D.O.; Kim, M.O.; Choi, Y.H.; Lee, H.G.; Kim, N.D.; Kim, G.Y. Gossypol suppresses telomerase activity in human leukemia cells via regulating hTERT. FEBS Lett. 2008, 582, 3367-3373.
123. Kim, M.O.; Moon, D.O.; Kang, S.H.; Heo, M.S.; Choi, Y.H.; Jung, J.H.; Lee, J.D.; Kim, G.Y. Pectenotoxin-2 represses telomerase activity in human leukemia cells through suppression of hTERT gene expression and Akt-dependent hTERT phosphorylation. FEBS Lett. 2008, 582, 3263-3269.
124. Liao, C.H.; Hsiao, Y.M.; Sheu, G.T.; Chang, J.T.; Wang, P.H.; Wu, M.F.; Shieh, G.J.; Hsu, C.P.; Ko, J.L. Nuclear translocation of telomerase reverse transcriptase and calcium signaling in repression of telomerase activity in human lung cancer cells by fungal immunomodulatory protein from Ganoderma tsugae. Biochem. Pharmacol. 2007, 74, 1541-1554.
125. Moon, D.O.; Kang, S.H.; Kim, K.C.; Kim, M.O.; Choi, Y.H.; Kim, G.Y. Sulforaphane decreases viability and telomerase activity in hepatocellular carcinoma Hep3B cells through the reactive oxygen species-dependent pathway. Cancer Lett. 2010, 295, 260-266.
126. Dasgupta, P.; Sengupta, S.B. Role of diallyl disulfide-mediated cleavage of c-Myc and Sp-1 in the regulation of telomerase activity in human lymphoma cell line U937. Nutrition 2015, 31, 1031-1037.
127. Ji, Z.N.; Ye, W.C.; Liu, G.Q.; Huang, Y. Inhibition of telomerase activity and bcl-2 expression in berbamine-induced apoptosis in HL-60 cells. Planta Med. 2002, 68, 596-600.
128. Tippani, R.; Prakhya, L.J.; Porika, M.; Sirisha, K.; Abbagani, S.; Thammidala, C. Pterostilbene as a potential novel telomerase inhibitor: Molecular docking studies and its in vitro evaluation. Curr. Pharm. Biotechnol. 2014, 14, 1027-1035.
129. Herz, C.; Tran, H.T.T.; Landerer, S.; Gaus, J.; Schlotz, N.; Lehr, L.; Schäfer, W.R.; Treeck, O.; Odongo, G.A.; Skatchkov, I.; et al. Normal human immune cells are sensitive to telomerase inhibition by Brassica-derived 3, 3-diindolylmethane, partly mediated via ERα/β-AP1 signaling. Mol. Nutr. Food Res. 2017, 61.
130. Lin, X.; Cai, Y.-J.; Li, Z.-X.; Chen, Q.; Liu, Z.-L.; Wang, R. Structure determination, apoptosis induction, and telomerase inhibition of CFP-2, a novel lichenin from Cladonia furcata. Biochim. Biophys. Acta 2003, 1622, 99-108.
131. Lyu, S.Y.; Choi, S.H.; Park, W.B. Korean mistletoe lectin-induced apoptosis in hepatocarcinoma cells is associated with inhibition of telomerase via mitochondrial controlled pathway independent of p53. Arch. Pharm. Res. 2002, 25, 93-101.
132. Xin, N.; Hasan, M.; Li, W.; Li, Y. Juglans mandshurica Maxim extracts exhibit antitumor activity on HeLa cells in vitro. Mol. Med. Rep. 2014, 9, 1313-1318.
133. Warabi, K.; Matsunaga, S.; van Soest, R.W.; Fusetani, N. Dictyodendrins A-E, the first telomerase-inhibitory marine natural products from the sponge Dictyodendrilla verongiformis. J. Org. Chem. 2003, 68, 2765-2770.
134. Warabi, K.; Hamada, T.; Nakao, Y.; Matsunaga, S.; Hirota, H.; van Soest, R.W.; Fusetani, N. Axinelloside A, an unprecedented highly sulfated lipopolysaccharide inhibiting telomerase, from the marine sponge, Axinella infundibula. J. Am. Chem. Soc. 2005, 127, 13262-13270.
135. Herz, C.; Hertrampf, A.; Zimmermann, S.; Stetter, N.; Wagner, M.; Kleinhans, C.; Erlacher, M.; Schuler, J.; Platz, S.; Rohn, S.; et al. The isothiocyanate erucin abrogates telomerase in hepatocellular carcinoma cells in vitro and in an orthotopic xenograft tumour model of HCC. J. Cell Mol. Med. 2014, 18, 2393-2403.
136. Giridharan, P.; Somasundaram, S.T.; Perumal, K.; Vishwakarma, R.A.; Karthikeyan, N.P.; Velmurugan, R.; Balakrishnan, A. Novel substituted methylenedioxy lignin suppresses proliferation of cancer cells by inhibiting telomerase and activation of c-myc and caspases leading to apoptosis. Br. J. Cancer 2002, 87, 98-105.
137. Song, Y.Y.S.L.; Yang, Y.M.; Wang, X.J.; Huang, G.Q. Alteration of activities of telomerase in tanshinone IIA inducing apoptosis of the leukemia cells. Zhongguo Zhong Yao Za Zhi 2005, 30, 207-211.
138. Faezizadeh, Z.; Mesbah-Namin, S.A.; Allameh, A. The effect of silymarin on telomerase activity in the human leukemia cell line K562. Planta Med. 2012, 78, 899-902.
139. Yurtcu, E.; Darcansoy Iseri, O.; Iffet Sahin, F. Effects of silymarin and silymarin-doxorubicin applications on telomerase activity of human hepatocellularcarcinoma cell line HepG2. J. BUON 2015, 20, 555-561.
140. Kim, M.Y.; Vankayalapati, H.; Shin-Ya, K.; Wierzba, K.; Hurley, L.H. Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular G-quadruplex. J. Am. Chem. Soc. 2002, 124, 2098-2099.
141. Duangmano, S.; Dakeng, S.; Jiratchariyakul, W.; Suksamrarn, A.; Smith, D.R.; Patmasiriwat, P. Antiproliferative effects of cucurbitacin B in breast cancer cells: Down-regulation of the c-Myc/hTERT/telomerase pathway and obstruction of the cell cycle. Int. J. Mol. Sci. 2010, 11, 5323-5338.
142. Liu, W.J.; Jiang, J.F.; Xiao, D.; Ding, J. Down-regulation of telomerase activity via protein phosphatase 2A activation in salvicine-induced human leukemia HL-60 cell apoptosis. Biochem. Pharmacol. 2002, 64, 1677-1687.
143. Yang, Y.; Sun, H.; Zhou, Y.; Ji, S.; Li, M. Effects of three diterpenoids on tumour cell proliferation and telomerase activity. Nat. Prod. Res. 2009, 23, 1007-1012.
144. Guo, J.M.; Kang, G.Z.; Xiao, B.X.; Li, D.H. Zhang. S. Effect of daidzein on cell growth, cell cycle, and telomerase activity of human cervical cancer in vitro. Int. J. Gynecol. Cancer 2004, 14, 882-888.
145. Zhang, F.; Jia, Z.; Deng, Z.; Wie, Y.; Zheng, R.; Yu, L. In vitro modulation of telomerase activity, telomere length and cell cycle in MKN45 cells by verbascoside. Planta Med. 2002, 68, 115-118.
146. Schmitz, F.J.; DeGuzman, F.S.; Hossain, M.B.; van der Helm, D. Cytotoxic aromatic alkaloids from the ascidian Amphicarpa meridiana and Leptoclinides sp.: Meridine and 11-hydroxyascididemin. J. Org. Chem. 1991, 56, 804-808.
147. Lu, Q.; Liu, W.; Ding, J.; Cai, J.; Duan, W. Shikonin derivatives: Synthesis and inhibition of human telomerase. Bioorg. Med. Chem. Lett. 2002, 12, 1375-1378.
148. Guittat, L.; Alberti, P.; Rosu, F.; Van Miert, S.; Thetiot, E.; Pieters, L.; Gabelica, V.; De Pauw, E.; Ottaviani, A.; Riou, J.-F.; et al. Interactions of cryptolepine and neocryptolepine with unusual DNA structures. Biochimie 2003, 85, 535-547.
149. Li, W.; Zhang, M.; Zhang, J.L.; Li, H.Q.; Zhang, X.C.; Sun, Q.; Qiu, C.M. Interactions of daidzin with intramolecular G-quadruplex. FEBS Lett. 2006, 580, 4905-4910.
150. Rafii, F. The role of colonic bacteria in the metabolism of the natural isoflavone daidzin to equol. Metabolites 2015, 5, 56-73.
151. Tomar, J.S. In-silico modeling studies of G-quadruplex with soy isoflavones having anticancerous activity. J. Mol. Model. 2015, 21, 193.
152. Zhang, J.L.; Fu, Y.; Zheng, L.; Li, W.; Li, H.; Sun, Q.; Xiao, Y.; Geng, F. Natural isoflavones regulate the quadruplex-duplex competition in human telomeric DNA. Nucleic Acids Res. 2009, 37, 2471-2482.
153. Guittat, L.; De Cian, A.; Rosu, F.; Gabelica, V.; De Pauw, E.; Delfourne, E.; Mergny, J.L. Ascididemin and meridine stabilise G-quadruplexes and inhibit telomerase in vitro. Biochim. Biophys. Acta 2005, 1724, 375-384.
154. Bai, L.P.; Hagihara, M.; Jiang, Z.H.; Nakatani, K. Ligand binding to tandem G quadruplexes from human telomeric DNA. Chembiochem 2008, 9, 2583-2587.
155. Banik, U.; Parasuraman, S.; Adhikary, A.K.; Othman, N.H. Curcumin: The spicy modulator of breast carcinogenesis. J. Exp. Clin. Cancer Res. 2017, 36, 98.
156. Griffiths, K.; Aggarwal, B.B.; Singh, R.B.; Buttar, H.S.; Wilson, D.; De Meester, F. Food antioxidants and their anti-inflammatory properties: A potential role in cardiovascular diseases and cancer prevention. Diseases 2016, 4, 28.
157. Siddappa, G.; Kulsum, S.; Ravindra, D.R.; Kumar, V.V.; Raju, N.; Raghavan, N.; Sudheendra, H.V.; Sharma, A.; Sunny, S.P.; Jacob, T.; et al. Curcumin and metformin-mediated chemoprevention of oral cancer is associated with inhibition of cancer stem cells. Mol. Carcinog. 2017, 56, 2446-2460.
158. Wang, X.P.; Wang, Q.X.; Lin, H.P.; Chang, N. Anti-tumor bioactivities of curcumin on mice loaded with gastric carcinoma. Food Funct. 2017, 8, 3319-3326.
159. Cui, S.X.; Qu, X.J.; Xie, Y.Y.; Zhou, L.; Nakata, M.; Makuuchi, M.; Tang, W. Curcumin inhibits telomerase activity in human cancer cell lines. Int. J. Mol. Med. 2006, 18, 227-231.
160. Chakraborty, S.; Ghosh, U.; Bhattacharyya, N.P.; Bhattacharya, R.K.; Roy, M. Inhibition of telomerase activity and induction of apoptosis by curcumin in K-562 cells. Mutat. Res. 2006, 596, 81-90.
161. Lee, J.H.; Chung, I.K. Curcumin inhibits nuclear localization of telomerase by dissociating the Hsp90 co-chaperone p23 from hTERT. Cancer Lett. 2010, 290, 76-86.
162. Hsin, I.L.; Sheu, G.T.; Chen, H.H.; Chiu, L.Y.; Wang, H.D.; Chan, H.W.; Hsu, C.P.; Ko, J.L. N-acetyl cysteine mitigates curcumin-mediated telomerase inhibition through rescuing of Sp1 reduction in A549 cells. Mutat. Res. 2010, 688, 72-77.
163. Singh, M.; Singh, N. Curcumin counteracts the proliferative effect of estradiol and induces apoptosis in cervical cancer cells. Mol. Cell. Biochem. 2011, 347, 1-11.
164. Lou, M.; Zhang, L.N.; Ji, P.G.; Feng, F.Q.; Liu, J.H.; Yang, C.; Li, B.F.; Wang, L. Quercetin nanoparticles induced autophagy and apoptosis through AKT/ERK/Caspase-3 signaling pathway in human neuroglioma cells: In vitro and in vivo. Biomed. Pharmacother. 2016, 84, 1-9.
165. Ren, K.W.; Li, Y.H.; Wu, G.; Ren, J.Z.; Lu, H.B.; Li, Z.M.; Han, X.W. Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells. Int. J. Oncol. 2017, 50, 1299-1311.
166. Naasani, I.; Oh-Hashi, F.; Oh-Hara, T.; Feng, W.Y.; Johnston, J.; Chan, K.; Tsuruo, T. Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. Cancer Res. 2003, 63, 824-830.
167. Avci, C.B.; Yilmaz, S.; Dogan, Z.O.; Saydam, G.; Dodurga, Y.; Ekiz, H.A.; Kartal, M.; Sahin, F.; Baran, Y.; Gunduz, C. Quercetin-induced apoptosis involves increased hTERT enzyme activity of leukemic cells. Hematology 2011, 16, 303-307.
168. Cosan, D.T.; Soyocak, A.; Basaran, A.; Degirmenci, I.; Gunes, H.V.; Sahin, F.M. Effects of various agents on DNA fragmentation and telomerase enzyme activities in adenocarcinoma cell lines. Mol. Biol. Rep. 2011, 38, 2463-2469.
169. Nakayama, Y.; Sakamoto, H.; Satoh, K.; Yamamoto, T. Tamoxifen and gonadal steroids inhibit colon cancer growth in association with inhibition of thymidylate synthase, survivin and telomerase expression through estrogen receptor beta mediated system. Cancer Lett. 2000, 161, 63-71.
170. Choi, J.A.; Kim, J.Y.; Lee, J.Y.; Kang, C.M.; Kwon, H.J.; Yoo, Y.D.; Kim, T.W.; Lee, Y.S.; Lee, S.J. Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int. J. Oncol. 2001, 19, 837-844.
171. Kuo, P.C.; Liu, H.F.; Chao, J.I. Survivin and p53 Modulate quercetin- induced cell growth inhibition and apoptosis in human lung carcinoma cells. J. Biol. Chem. 2004, 279, 55875-55885.
172. Lee, T.J.; Kim, O.H.; Kim, Y.H.; Lim, J.H.; Kim, S.; Park, J.W.; Kwon, T.K. Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells. Cancer Lett. 2006, 240, 234-242.
173. Kou, S.M. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett. 1996, 110, 41-48.
174. Gibellini, L.; Pinti, M.; Nasi, M.; Montagna, J.P.; Biasi, S.D.; Roat, E.; Bertoncelli, L.; Cooper, E.L.; Cossarizza, A. Quercetin and cancer chemoprevention. Evid. Based Complement. Altern. Med. 2011, 2011, 591356.
175. Cui, Y.; Han, Y.; Yang, X.; Sun, Y.; Zhao, Y. Protective effects of quercetin and quercetin-5′, 8-disulfonate against carbon tetrachloride-caused oxidative liver injury in mice. Molecules 2013, 19, 291-305.
176. Yang, C.; Gundala, S.R.; Mukkavilli, R.; Vangala, S.; Reid, M.D.; Aneja, R. Synergistic interactions among flavonoids and acetogenins in Graviola (Annona muricata) leaves confer protection against prostate cancer. Carcinogenesis 2015, 36, 656-665.
177. Doğan, Z.; Kocahan, S.; Erdemli, E.; Köse, E.; Yılmaz, I.; Ekincioğlu, Z.; Ekinci, N.; Turkoz, Y. Effect of chemotherapy exposure prior to pregnancy on fetal brain tissue and the potential protective role of quercetin. Cytotechnology 2015, 67, 1031-1038.
178. Oršolić, N.; Karač, I.; Sirovina, D.; Kukolj, M.; Kunštić, M.; Gajski, G.; Garaj-Vrhovac, V.; Štajcar, D. Chemotherapeutic potential of quercetin on human bladder cancer cells. J. Environ. Sci. Health A Tox. Hazard. Subst. Environ. Eng. 2016, 51, 776-781.
179. Parvaresh, A.; Razavi, R.; Rafie, N.; Ghiasvand, R.; Pourmasoumi, M.; Miraghajani, M. Quercetin and ovarian cancer: An evaluation based on a systematic review. J. Res. Med. Sci. 2016, 21, 34.
180. Teiten, M.H.; Gaascht, F.; Dicato, M.; Diederich, M. Targeting the wingless signaling pathway with natural compounds as chemopreventive or chemotherapeutic agents. Curr. Pharm. Biotechnol. 2012, 13, 245-254.
181. Chen, S.F.; Nien, S.; Wu, C.H.; Liu, C.L.; Chang, Y.C.; Lin, Y.S. Reappraisal of the anticancer efficacy of quercetin in oral cancer cells. J. Chin. Med. Assoc. 2013, 76, 146-152.
182. Tang, S.N.; Singh, C.; Nall, D.; Meeker, D.; Shankar, S.; Srivastava, R.K. The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelialmesenchymal transition. J. Mol. Signal. 2010, 5, 14.
183. Wang, J.; Zhang, P.H.; Tu, Z.G. Effects of quercetin on proliferation of lung cancer cell line A549 by down-regulating hTERT gene expression. J. Third Mil. Med. Univ. 2007, 29, 1852-1854.
184. Wei, J.W.; Fan, Y.; Zhang, Y.L.; Wu, Y. Effects of quercetin on telomerase activity and apoptosis in gastric cancer cells. Shandong Med. J. 2007, 35, 15.
185. Behjati, M.; Hashemi, M.; Kazemi, M.; Salehi, M.; Javanmard, S.H. Evaluation of energy balance on human telomerase reverse transcriptase (hTERT) alternative splicing by semi-quantitative RT-PCR in human umbilical vein endothelial cells. Adv. Biomed. Res. 2017, 6, 43.
186. Zheng, D.S.; Chen, L.S. Triterpenoids from Ganoderma lucidum inhibit the activation of EBV antigens as telomerase inhibitors. Exp. Ther. Med. 2017, 14, 3273-3278.
187. Kuhar, M.; Imran, S.; Singh, N. Curcumin and quercetin combined with cisplatin to induce apoptosis in human laryngeal carcinoma Hep-2 cells through the mitochondrial pathway. J. Cancer Mol. 2007, 3, 121-128.
188. Zamin, L.L.; Filippi-Chiela, E.C.; Dillenburg-Pilla, P.; Horn, F.; Salbego, C.; Lenz, G. Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells. Cancer Sci. 2009, 100, 1655-1662.
189. Ak, A.; Basaran, A.; Dikmen, M.; Turgut Cosan, D.; Degirmenci, I.; Gunes, H.V. Evaluation of effects of quercetin (3, 3′, 4′, 5, 7-pentohidroxyfl avon) on apoptosis and telomerase enzyme activity in MCF-7 and NIH-3T3 cell lines compared with tamoxifen. Balkan Med. J. 2011, 28, 293-299.
190. Shen, X.; Wang, M.; Bi, X.; Zhang, J.; Wen, S.; Fu, G.; Xia, L. Resveratrol prevents endothelial progenitor cells from senescence and reduces the oxidative reaction via PPARγ/HO1 pathways. Mol. Med. Rep. 2016, 14, 5528-5534.
191. Daniel, M.; Tollefsbol, T.O. Pterostilbene down-regulates hTERT at physiological concentrations in breast cancer cells: Potentially through the inhibition of cMyc. J. Cell. Biochem. 2017.
192. Chen, R.J.; Wu, P.H.; Ho, C.T.; Way, T.D.; Pan, M.H.; Chen, H.M.; Ho, Y.S.; Wang, Y.J. P53-dependent downregulation of hTERT protein expression and telomerase activity induces senescence in lung cancer cells as a result of pterostilbene treatment. Cell Death Dis. 2017, 8, e2985.
193. Fuggetta, M.P.; Lanzilli, G.; Tricarico, M.; Cottarelli, A.; Falchetti, R.; Ravagnan, G.; Bonmassar, E. Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro. J. Exp. Clin. Cancer Res. 2006, 25, 189-193.
194. Perrone, D.; Fuggetta, M.P.; Ardito, F.; Cottarelli, A.; De Filippis, A.; Ravagnan, G.; De Maria, S.; Lo Muzio, L. Resveratrol (3, 5, 4′-trihydroxystilbene) and its properties in oral diseases. Exp. Ther. Med. 2017, 14, 3-9.
195. Aziz, S.W.; Aziz, M.H. Protective molecular mechanisms of resveratrol in UVR-induced skin carcinogenesis. Photodermatol. Photoimmunol. Photomed. 2017.
196. Guthrie, A.R.; Chow, H.S.; Martinez, J.A. Effects of resveratrol on drug- and carcinogen-metabolizing enzymes, implications for cancer prevention. Pharmacol. Res. Perspect. 2017, 5, e00294.
197. Wang, X.Y.; Fan, Y.; Zhang, Y.L.; Zhong, X.M. Effect of resveratrol on promoter and human telomerase reverse transcriptase (hTERT) expression of human colorectal carcinoma cell. J. Jiangsu Univ. 2010, 23, 3-23.
198. Zhai, X.X.; Ding, J.C.; Tang, Z.M.; Li, J.G.; Li, Y.C.; Yan, Y.H.; Sun, J.C.; Zhang, C.X. Effects of resveratrol on the proliferation, apoptosis and telomerase ability of human A431 epidermoid carcinoma cells. Oncol. Lett. 2016, 11, 3015-3018.
199. Zielińska-Przyjemska, M.; Kaczmarek, M.; Krajka-Kuźniak, V.; Łuczak, M.; Baer-Dubowska, W. The effect of resveratrol, its naturally occurring derivatives and tannic acid on the induction of cell cycle arrest and apoptosis in rat C6 and human T98G glioma cell lines. Toxicol. In Vitro 2017, 43, 69-75.
200. Jordan, L.G.; Booth, B.W. HER2+ breast cancer cells undergo apoptosis upon exposure to tannic acid released from remodeled cross-linked collagen type I. J. Biomed. Mater. Res. A 2017.
201. Zhang, J.; Cui, L.; Han, X.; Zhang, Y.; Zhang, X.; Chu, X.; Zhang, F.; Zhang, Y.; Chu, L. Protective effects of tannic acid on acute doxorubicin-induced cardiotoxicity: Involvement of suppression in oxidative stress, inflammation, and apoptosis. Biomed. Pharmacother. 2017, 93, 1253-1260.
202. Shimozu, Y.; Kimura, Y.; Esumi, A.; Aoyama, H.; Kuroda, T.; Sakagami, H.; Hatano, T. Ellagitannins of Davidia involucrata L. structure of davicratinic acid a and effects of davidia tannins on drug-resistant bacteria and human oral squamous cell carcinomas. Molecules 2017, 22, 470.
203. Fu, S.; Yang, Y.; Liu, D.; Luo, Y.; Ye, X.; Liu, Y.; Chen, X.; Wang, S.; Wu, H.; Wang, Y.; et al. Flavonoids and tannins from Smilax china L. rhizome induce apoptosis via mitochondrial pathway and MDM2-p53 signaling in human lung adenocarcinoma cells. Am. J. Chin. Med. 2017, 45, 369-384.
204. Darvin, P.; Joung, Y.H.; Kang, D.Y.; Sp, N.; Byun, H.J.; Hwang, T.S.; Sasidharakurup, H.; Lee, C.H.; Cho, K.H.; Park, K.D.; et al. Tannic acid inhibits EGFR/STAT1/3 and enhances p38/STAT1 signalling axis in breast cancer cells. J. Cell Mol. Med. 2017, 21, 720-734.
205. Adaramoye, O.; Erguen, B.; Nitzsche, B.; Höpfner, M.; Jung, K.; Rabien, A. Punicalagin, a polyphenol from pomegranate fruit, induces growth inhibition and apoptosis in human PC-3 and LNCaP cells. Chem. Biol. Interact. 2017, 274, 100-106.
206. Pumiputavon, K.; Chaowasku, T.; Saenjum, C.; Osathanunkul, M.; Wungsintaweekul, B.; Chawansuntati, K.; Wipasa, J.; Lithanatudom, P. Cell cycle arrest and apoptosis induction by methanolic leaves extracts of four Annonaceae plants. BMC Complement. Altern. Med. 2017, 17, 294.
207. Gali-Muhtasib, H.U.; Yamout, S.Z.; Sidani, M.M. Tannins protect against skin tumor promotion induced by ultraviolet-B radiation in hairless mice. Nutr. Cancer 2000, 37, 73-77.
208. Tietbohl, L.A.C.; Oliveira, A.P.; Esteves, R.S.; Albuquerque, R.D.D.G.; Folly, D.; Machado, F.P.; Corrêa, A.L.; Santos, M.G.; Ruiz, A.L.G.; Rocha, L. Antiproliferative activity in tumor cell lines, antioxidant capacity and total phenolic, flavonoid and tannin contents of Myrciaria floribunda. An. Acad. Bras. Cienc. 2017, 89, 1111-1120.
209. Vergara-Jimenez, M.; Almatrafi, M.M.; Fernandez, M.L. Bioactive components in Moringa Oleifera leaves protect against chronic disease. Antioxidants 2017, 6, 91.
210. Singh, S.; Dubey, V.; Singh, D.K.; Fatima, K.; Ahmad, A.; Luqman, S. Antiproliferative and antimicrobial efficacy of the compounds isolated from the roots of Oenothera biennis L. J. Pharm. Pharmacol. 2017, 69, 1230-1243.
211. Kumar, N.; Biswas, S.; Mathew, A.E.; Varghese, S.; Mathew, J.E.; Nandakumar, K.; Aranjani, J.M.; Lobo, R. Pro-apoptotic and cytotoxic effects of enriched fraction of Elytranthe parasitica (L.) Danser against HepG2 hepatocellular carcinoma. BMC Complement. Altern Med. 2016, 16, 420.
212. Colomer, R.; Sarrats, A.; Lupu, R.; Puig, T. Natural polyphenols and their synthetic analogs as emerging anticancer agents. Curr. Drug Target 2017, 18, 147-159.
213. Liu, Y.B.; Gao, X.; Deeb, D.; Pindolia, K.; Gautam, S.C. Role of telomerase in anticancer activity of pristimerin in prostate cancer cells. J. Exp. Ther. Oncol. 2017, 11, 41-49.
214. Moradzadeh, M.; Hosseini, A.; Erfanian, S.; Rezaei, H. Epigallocatechin-3-gallate promotes apoptosis in human breast cancer T47D cells through down-regulation of PI3K/AKT and telomerase. Pharmacol. Rep. 2017, 69, 924-928.
215. Gurung, R.L.; Lim, S.N.; Low, G.K.; Hande, M.P. MST-312 alters telomere dynamics, gene expression profiles and growth in human breast cancer cells. J. Nutrigenet. Nutrigenom. 2014, 7, 283-298.
216. Fatemi, A.; Safa, M.; Kazemi, A. MST-312 induces G2/M cell cycle arrest and apoptosis in APL cells through inhibition of telomerase activity and suppression of NF-κB pathway. Tumour Biol. 2015, 36, 8425-8437.
217. Liu, L.; Zuo, J.; Wang, G. Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis in Ec9706 and Eca109 esophageal carcinoma cells. Oncol. Lett. 2017, 14, 4391-4395.
218. Zhang, W.; Yang, P.; Gao, F.; Yang, J.; Yao, K. Effects of epigallocatechin gallate on the proliferation and apoptosis of the nasopharyngeal carcinoma cell line CNE2. Exp. Ther. Med. 2014, 8, 1783-1788.
219. Gerhardt, D.; Bertola, G.; Dietrich, F.; Figueiró, F.; Zanotto-Filho, A.; Moreira Fonseca, J.C.; Morrone, F.B.; Barrios, C.H.; Battastini, A.M.; Salbego, C.G. Boldine induces cell cycle arrest and apoptosis in T24 human bladder cancer cell line via regulation of ERK, AKT, and GSK-3β. Urol. Oncol. 2014, 32, 36.e1-36.e9.
220. Gerhardt, D.; Horn, A.P.; Gaelzer, M.M.; Frozza, R.L.; Delgado-Cañedo, A.; Pelegrini, A.L.; Henriques, A.T.; Lenz, G.; Salbego, C. Boldine: A potential new antiproliferative drug against glioma cell lines. Invest. New Drugs 2009, 27, 517-525.
221. Noureini, S.K.; Wink, M. Dose-dependent cytotoxic effects of boldine in HepG-2 cells-telomerase inhibition and apoptosis induction. Molecules 2015, 20, 3730-3743.
222. Paydar, M.; Kamalidehghan, B.; Wong, Y.L.; Wong, W.F.; Looi, C.Y.; Mustafa, M.R. Evaluation of cytotoxic and chemotherapeutic properties of boldine in breast cancer using in vitro and in vivo models. Drug Des. Dev. Ther. 2014, 8, 719-733.
223. Imanshahidi, M.; Hosseinzadeh, H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother. Res. 2008, 22, 999-1012.
224. Wu, H.L.; Hsu, C.Y.; Liu, W.H.; Yung, B.Y. Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity. Int. J. Cancer 1999, 81, 923-929.
225. Naasani, I.; Seimiya, H.; Yamori, T.; Tsuruo, T. FJ5002: A potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis. Cancer Res. 1999, 59, 4004-4011.
226. Zhang, W.J.; Ou, T.M.; Lu, Y.J.; Huang, Y.Y.; Wu, W.B.; Huang, Z.S.; Zhou, J.L.; Wong, K.Y.; Gu, L.Q. 9-Substituted berberine derivatives as G-quadruplex stabilizing ligands in telomeric DNA. Bioorg. Med. Chem. 2007, 15, 5493-5501.
227. Ma, Y.; Ou, T.M.; Hou, J.Q.; Lu, Y.J.; Tan, J.H.; Gu, L.Q.; Huang, Z.S. 9-N-Substituted berberine derivatives: Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc. Bioorg. Med. Chem. 2008, 16, 7582-7591.
228. Ma, Y.; Ou, T.M.; Tan, J.H.; Hou, J.Q.; Huang, S.L.; Gu, L.Q.; Huang, Z.S. Synthesis and evaluation of 9-O-substituted berberine derivatives containing aza-aromatic terminal group as highly selective telomeric G-quadruplex stabilizing ligands. Bioorg. Med. Chem. Lett. 2009, 19, 3414-3417.
229. Cevatemre, B.; Erkısa, M.; Aztopal, N.; Karakas, D.; Alper, P.; Tsimplouli, C.; Sereti, E.; Dimas, K.; Armutak, E.I.I.; Gurevin, E.G.; et al. A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer. Pharmacol. Res. 2017.
230. Wu, C.C.; Chan, M.L.; Chen, W.Y.; Tsai, C.Y.; Chang, F.R.; Wu, Y.C. Pristimerin induces caspase-dependent apoptosis in MDA-MB-231 cells via direct effects on mitochondria. Mol. Cancer Ther. 2005, 4, 1277-1285.
231. Yang, H.; Landis-Piwowar, K.R.; Lu, D.; Yuan, P.; Li, L.; Reddy, G.P.; Yuan, X.; Dou, Q.P. Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells. J. Cell. Biochem. 2008, 103, 234-244.
232. Byun, J.Y.; Kim, M.J.; Eum, D.Y.; Yoon, C.H.; Seo, W.D.; Park, K.H.; Hyun, J.W.; Lee, Y.S.; Lee, J.S.; Yoon, M.Y.; et al. Reactive oxygen species-dependent activation of Bax and poly(ADP-ribose) polymerase-1 is required for mitochondrial cell death induced by triterpenoid pristimerin in human cervical cancer cells. Mol. Pharmacol. 2009, 76, 734-744.
233. Tiedemann, R.E.; Schmidt, J.; Keats, J.J.; Shi, C.X.; Zhu, Y.X.; Palmer, S.E.; Mao, X.; Schimmer, A.D.; Stewart, A.K. Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-kappaB with antimyeloma activity in vitro and in vivo. Blood 2009, 113, 4027-4037.
234. Deeb, D.; Gao, X.; Liu, Y.; Pindolia, K.; Gautam, S.C. Inhibition of hTERT/telomerase contributes to the antitumor activity of pristimerin in pancreatic ductal adenocarcinoma cells. Oncol. Rep. 2015, 34, 518-524.
235. Deeb, D.; Gao, X.; Liu, Y.; Varma, N.R.; Arbab, A.S.; Gautam, S.C. Inhibition of telomerase activity by oleanane triterpenoid CDDO-Me in pancreatic cancer cells is ROS-dependent. Molecules 2013, 18, 3250-3265.
236. Yore, M.M.; Liby, K.T.; Honda, T.; Gribble, G.W.; Sporn, M.B. The synthetic triterpenoid 1-[2-cyano-3, 12-dioxooleana-1, 9-dien-28-oyl]imidazole blocks nuclear factor-kappaB activation through direct inhibition of IkappaB kinase beta. Mol. Cancer Ther. 2006, 5, 3232-3239.
237. Liu, Y.; Gao, X.; Deeb, D.; Arbab, A.S.; Gautam, S.C. Telomerase reverse transcriptase (TERT) is a therapeutic target of oleanane triterpenoid CDDO-Me in prostate cancer. Molecules 2012, 17, 14795-14809.
238. Deeb, D.; Gao, X.; Liu, Y.; Kim, S.H.; Pindolia, K.R.; Arbab, A.S.; Gautam, S.C. Inhibition of cell proliferation and induction of apoptosis by oleanane triterpenoid (CDDO-Me) in pancreatic cancer cells is associated with the suppression of hTERT gene expression and its telomerase activity. Biochem. Biophys. Res. Commun. 2012, 422, 561-567.
239. Wang, X.; Chen, Y.; Han, Q.B.; Chan, C.Y.; Wang, H.; Liu, Z.; Cheng, C.H.; Yew, D.T.; Lin, M.C.; He, M.L.; et al. Proteomic identification of molecular targets of gambogic acid: Role of stathmin in hepatocellular carcinoma. Proteomics 2009, 9, 242-253.
240. Zhao, T.; Wang, H.J.; Zhao, W.W.; Sun, Y.L.; Hu, L.K. Gambogic acid improves non-small cell lung cancer progression by inhibition of mTOR signaling pathway. Kaohsiung J. Med. Sci. 2017, 33, 543-549.
241. Zhang, D.; Zou, Z.; Ren, W.; Qian, H.; Cheng, Q.; Ji, L.; Liu, B.; Liu, Q. Gambogic acid-loaded PEG-PCL nanoparticles act as an effective antitumor agent against gastric cancer. Pharm. Dev. Technol. 2017, 3, 1-8.
242. Pan, H.; Jansson, K.H.; Beshiri, M.L.; Yin, J.; Fang, L.; Agarwal, S.; Nguyen, H.; Corey, E.; Zhang, Y.; Liu, J.; et al. Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancer. Oncotarget 2017, 8, 77181-77194.
243. Li, Q.; Cheng, H.; Zhu, G.; Yang, L.; Zhou, A.; Wang, X.; Fang, N.; Xia, L.; Su, J.; Wang, M.; et al. Gambogenic acid inhibits proliferation of A549 cells through apoptosis-inducing and cell cycle arresting. Biol. Pharm. Bull. 2010, 33, 415-420.
244. Fu, W.M.; Zhang, J.F.; Wang, H.; Tan, H.S.; Wang, W.M.; Chen, S.C.; Zhu, X.; Chan, T.M.; Tse, C.M.; Leung, K.S.; et al. Apoptosis induced by 1, 3, 6, 7-tetrahydroxyxanthone in hepatocellular carcinoma and proteomic analysis. Apoptosis 2012, 17, 842-851.
245. Guo, Q.L.; Lin, S.S.; You, Q.D.; Gu, H.Y.; Yu, J.; Zhao, L.; Qi, Q.; Liang, F.; Tan, Z.; Wang, X. Inhibition of human telomerase reverse transcriptase gene expression by gambogic acid in human hepatoma SMMC-7721 cells. Life Sci. 2006, 78, 1238-1245.
246. Yu, J.; Guo, Q.L.; You, Q.D.; Zhao, L.; Gu, H.Y.; Yang, Y.; Zhang, H.W.; Tan, Z.; Wang, X. Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells. Carcinogenesis 2007, 28, 632-638.